Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Xilio Therapeutics (XLO) Long-Term Debt Repayments (2024)

Historic Long-Term Debt Repayments for Xilio Therapeutics (XLO) over the last 1 years, with Q1 2024 value amounting to $3.3 million.

  • Xilio Therapeutics' Long-Term Debt Repayments changed N/A to $3.3 million in Q1 2024 from the same period last year, while for Dec 2024 it was $3.3 million, marking a year-over-year change of. This contributed to the annual value of $3.3 million for FY2024, which is 5000.75% down from last year.
  • As of Q1 2024, Xilio Therapeutics' Long-Term Debt Repayments stood at $3.3 million.
  • In the past 5 years, Xilio Therapeutics' Long-Term Debt Repayments registered a high of $3.3 million during Q1 2024, and its lowest value of $3.3 million during Q1 2024.